Laxxon Medical to Attend 42nd Annual J.P. Morgan Healthcare Conference in San Francisco

NEW YORK, NY / ACCESSWIRE / December 6, 2023 / Laxxon Medical announced today its attendance at the 42nd Annual J.P. Morgan Healthcare Conference, taking place January 8-11, 2024, in San Francisco, California. The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, connecting global industry leaders, emerging fast-growth companies and innovative technologies of the investment community.

Representing Laxxon Medical at the J.P.Morgan Healthcare Conference is CEO Helmut Kerschbaumer and Chief Strategy Officer Alexander Ruckdaeschel, who will meet with institutional investors.

About Laxxon Medical
Laxxon Medical is a pharma-technology company pioneering a new generation of advanced pharmaceuticals with SPID®, a novel 3D screen printing platform technology. For new and common pharmaceutical drugs, SPID® unlocks innovative drug delivery advancements paired with fast-tracked market access and extensive IP protection to yield disruptive opportunities for partners and life-changing results for patients.

Laxxon’s pipeline includes ongoing working-projects with notable pharma players, biotech companies and research universities, in addition to 13 in-house Advanced Patented Generics products. Laxxon’s IP is continuously growing and consists of 150 patents and patent applications with more than 3,000 patent claims.

Laxxon is partnered with CDMO Hovione and is jointly establishing cGMP productions in Portugal and the United States.

Company website: www.laxxonmedical.com.

Company Contact
Frances Hoggard | Communications Manager | f.hoggard@laxxonmedical.com

SOURCE: Laxxon Medical

View source version on accesswire.com:
https://www.accesswire.com/813750/laxxon-medical-to-attend-42nd-annual-jp-morgan-healthcare-conference-in-san-francisco

Staff

Recent Posts

Nano Dimension to Acquire Desktop Metal, Creating a Leader in Additive Manufacturing

Well-Capitalized Combined Company with Strong Financial Profile and 2023 Revenue of $246M, 28% from Recurring…

2 hours ago

CHOWIS to Develop Customized Cosmetics Diagnostic Platform in Partnership With Kolmar Korea

Chowis Co. Ltd. Skin, Hair and Scalp Solutions Provider Signs Agreement with Kolmar Korea to…

2 hours ago

Rose Villa Senior Living and The Malden Collective Partner to Launch the LiveWell(R) Tech Accelerator

PORTLAND, OR / ACCESSWIRE / July 3, 2024 / Rose Villa Senior Living continues to…

2 hours ago

Delota Reports First Quarter Revenue of $9.9 Million and Positive Adjusted EBITDA

Highlights:Total revenue of $9.9 million for Q1 2025, reflecting YoY growth of 31% from the…

3 hours ago

Therma Bright Q2, 2024 Market Update On Business

Medical Device Developer & Investor Taps 4 Markets With Growth Projections of USD $39.1B by…

4 hours ago

Danish start-up Kvantify secures EUR 10 million seed round to unlock quantum computing potential, starting with life sciences

The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and…

5 hours ago